June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Spleen as a source for myeloid cells infiltrating the diabetic retina
Author Affiliations & Notes
  • Eleni Beli
    OPHTHALMOLOGY, IUPUI, Indianapolis, Indiana, United States
  • Sergio Li Calzi
    OPHTHALMOLOGY, IUPUI, Indianapolis, Indiana, United States
  • Yaqian Duan
    OPHTHALMOLOGY, IUPUI, Indianapolis, Indiana, United States
  • Sergio Caballero
    Pharmacology, University of Florida, Gainesville, Florida, United States
  • Julia V Busik
    Physiology, Michigan State University, East Lansing, Michigan, United States
  • Maria B Grant
    OPHTHALMOLOGY, IUPUI, Indianapolis, Indiana, United States
  • Footnotes
    Commercial Relationships   Eleni Beli, None; Sergio Li Calzi, None; Yaqian Duan, None; Sergio Caballero, None; Julia Busik, None; Maria Grant, None
  • Footnotes
    Support  R01EY0126001, R01EY007739, R01HL110170, R01DK090730. Research to Prevent Blindness Unrestricted grant awarded to the Department of Ophthalmology at IUPUI.
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2507. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Eleni Beli, Sergio Li Calzi, Yaqian Duan, Sergio Caballero, Julia V Busik, Maria B Grant; Spleen as a source for myeloid cells infiltrating the diabetic retina. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2507.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Leukocyte infiltration in the diabetic retinas has been described in both clinical and experimental settings, but their source, phenotype and role of these cells in the progression of diabetic retinopathy is not clear. We asked whether the spleen is a source of leukocyte infiltration in the retina, and how diabetes affects leukocyte recruitment.

Methods : Retinal ischemia reperfusion (I/R) model was used in sham-operated and splenectomized C57BL/6 mice. Flow cytometry was performed in the retinas 24hrs post I/R and the phenotype of infiltrating cells was examined. The content of myeloid cells in the spleen of STZ-diabetic mice (4 months of diabetes) was examined at ZT5 (day) and ZT17 (night) of a day/night cycle (ZT= Zeitgeber Time; hrs after the lights go on). I/R was conducted at ZT5 and ZT17 to examine how the myeloid content of the spleen affects the recruitment of myeloid cells into the retina of diabetic and control animals.

Results : I/R induced significant infiltration of CD45hi CD11b+ myeloid cells (neutrophils, macrophages and monocytes) into the retina. The level of infiltration was reduced significantly in splenectomized mice, suggesting that the spleen is a major source of recruited leukocytes. Under normal diurnal conditions the diabetic mice had increased Ly6Chi splenic monocyte content at ZT17. When I/R was induced at that time, the infiltration of myeloid cells in the retina was also significantly increased compared to controls, who had fewer Ly6Chi monocytes at that time.

Conclusions : We show that splenic monocytes are recruited in the retina after ischemic injury and that the content of splenic myeloid cells correlates with the level of infiltrating cells. These results put the spleen on the spotlight for targeting diabetic complications.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×